Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 719

Similar articles for PubMed (Select 18843661)

1.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004562. doi: 10.1002/14651858.CD004562.pub3. Review. Update in: Cochrane Database Syst Rev. 2009;(4):CD004562.

PMID:
18843661
2.

LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.

Goel S, Sharma R, Hamilton A, Beith J.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD004562. doi: 10.1002/14651858.CD004562.pub4. Review.

PMID:
19821328
3.

Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials.

LHRH-agonists in Early Breast Cancer Overview group, Cuzick J, Ambroisine L, Davidson N, Jakesz R, Kaufmann M, Regan M, Sainsbury R.

Lancet. 2007 May 19;369(9574):1711-23.

PMID:
17512856
4.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG).

Lancet. 2005 May 14-20;365(9472):1687-717.

PMID:
15894097
5.

Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials.

Klijn JG, Blamey RW, Boccardo F, Tominaga T, Duchateau L, Sylvester R; Combined Hormone Agents Trialists' Group and the European Organization for Research and Treatment of Cancer.

J Clin Oncol. 2001 Jan 15;19(2):343-53.

PMID:
11208825
6.

Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.

Hackshaw A, Baum M, Fornander T, Nordenskjold B, Nicolucci A, Monson K, Forsyth S, Reczko K, Johansson U, Fohlin H, Valentini M, Sainsbury R.

J Natl Cancer Inst. 2009 Mar 4;101(5):341-9. doi: 10.1093/jnci/djn498. Epub 2009 Feb 24.

7.

WITHDRAWN: Tamoxifen for early breast cancer.

Clarke MJ.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000486. doi: 10.1002/14651858.CD000486.pub2. Review.

PMID:
18843611
8.

Tamoxifen for early breast cancer.

Early Breast Cancer Trialists' Collaborative Group.

Cochrane Database Syst Rev. 2001;(1):CD000486. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD000486.

PMID:
11279694
9.

Complete estrogen blockade for the treatment of metastatic and early stage breast cancer.

Michaud LB, Buzdar AU.

Drugs Aging. 2000 Apr;16(4):261-71. Review.

PMID:
10874521
10.

WITHDRAWN: Ovarian ablation for early breast cancer.

Clarke MJ.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000485. doi: 10.1002/14651858.CD000485.pub2. Review.

PMID:
18843610
11.

Ovarian ablation for early breast cancer.

Early Breast Cancer Trialists' Collaborative Group.

Cochrane Database Syst Rev. 2000;(3):CD000485. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD000485.

PMID:
10908474
12.

Systematic review of LHRH agonists for the adjuvant treatment of early breast cancer.

Sharma R, Beith J, Hamilton A.

Breast. 2005 Jun;14(3):181-91. Epub 2005 Apr 26. Review.

PMID:
15927827
13.

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.

Sverrisdottir A, Johansson H, Johansson U, Bergh J, Rotstein S, Rutqvist L, Fornander T.

Breast Cancer Res Treat. 2011 Aug;128(3):755-63. doi: 10.1007/s10549-011-1593-0. Epub 2011 May 29.

PMID:
21625929
14.

Ovarian ablation for early breast cancer.

Early Breast Cancer Trialists' Collaborative Group.

Cochrane Database Syst Rev. 2000;(2):CD000485. Review. Update in: Cochrane Database Syst Rev. 2000;(3):CD000485.

PMID:
10796722
15.
16.

Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.

International Breast Cancer Study Group (IBCSG), Castiglione-Gertsch M, O'Neill A, Price KN, Goldhirsch A, Coates AS, Colleoni M, Nasi ML, Bonetti M, Gelber RD.

J Natl Cancer Inst. 2003 Dec 17;95(24):1833-46.

17.
18.

WITHDRAWN: Multi-agent chemotherapy for early breast cancer.

Clarke MJ.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD000487. doi: 10.1002/14651858.CD000487.pub2. Review.

PMID:
18843612
19.

Luteinizing hormone-releasing hormone agonists in premenopausal hormone receptor-positive breast cancer.

Tan SH, Wolff AC.

Clin Breast Cancer. 2007 Feb;7(6):455-64. Review.

PMID:
17386122
20.

Multi-agent chemotherapy for early breast cancer.

Early Breast Cancer Trialists' Collaborative Group.

Cochrane Database Syst Rev. 2002;(1):CD000487. Review. Update in: Cochrane Database Syst Rev. 2008;(4):CD000487.

PMID:
11869577
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk